Live TVMarketsFinanceEconomicsIndustriesTechReal EstateSmall BusinessPoliticsVideo
Top SecuritiesDOW (DIA) $517.13 ▼1.07%S&P 500 (SPY) $755.72 ▼1.77%NASDAQ 25,437 ▼2.86%10Y 4.94% ▼4 bpBITCOIN $77,820 ▲0.37%NASDAQ 100 (QQQ) $690.49 ▼3.47%30Y MORTGAGE 7.24% ▼0.08
Sunday, November 1, 2026 Edition · Raleigh 61° Mostly Clear Watch Live Sign in Subscribe
GENIUS EYEGET NewsA service of The GET Network, Inc.
Markets
DOW (DIA) $517.13 -1.07%S&P 500 (SPY) $755.72 -1.77%NASDAQ 25,437 -2.86%10Y 4.94% -4 bpBITCOIN $77,820 +0.37%NASDAQ 100 (QQQ) $690.49 -3.47%30Y MORTGAGE 7.24% -0.08United's MileagePlus head discusses future loyalty program changes after 2026 credit card expansionsMan dies on Howe Avenue in Sacramento, police investigateTop travel destinations and credit card bonuses for November 2026Documentary 'You Can See Everything' and film 'Clayface' vie for top box office spotRavens place Lamar Jackson on injured reserve after thumb injuryTovah Feldshuh says tensions not rising on 'Nobody Wants This' set amid Israel-Palestine debateCleft lip filler treatments boost confidence but raise exploitation concernsScientists develop new ultrasound method to target deadly brain cancerDOW (DIA) $517.13 -1.07%S&P 500 (SPY) $755.72 -1.77%NASDAQ 25,437 -2.86%10Y 4.94% -4 bpBITCOIN $77,820 +0.37%NASDAQ 100 (QQQ) $690.49 -3.47%30Y MORTGAGE 7.24% -0.08United's MileagePlus head discusses future loyalty program changes after 2026 credit card expansionsMan dies on Howe Avenue in Sacramento, police investigateTop travel destinations and credit card bonuses for November 2026Documentary 'You Can See Everything' and film 'Clayface' vie for top box office spotRavens place Lamar Jackson on injured reserve after thumb injuryTovah Feldshuh says tensions not rising on 'Nobody Wants This' set amid Israel-Palestine debateCleft lip filler treatments boost confidence but raise exploitation concernsScientists develop new ultrasound method to target deadly brain cancer
Wellness

Common pesticide linked to 2.5 times higher risk of Parkinson’s disease

UCLA study finds long-term exposure to pesticide chlorpyrifos increases Parkinson’s risk and reveals how it harms brain cells.

Nov 1, 2026, 4:36 PM By the Genius Eye newsroom (Wellness Reporter) · Fact-checkedHow we report
Jurriaanlinsen / CC BY-SA 4.0, via Wikimedia Commons

A study by UCLA Health reported that long-term residential exposure to chlorpyrifos, a widely used pesticide, is associated with more than 2.5 times the risk of developing Parkinson’s disease compared to those not exposed.

The researchers found that chlorpyrifos interferes with the brain’s ability to remove damaged proteins, leading to the loss of nerve cells essential for controlling movement, which is a key feature of Parkinson’s disease.

Parkinson’s disease affects nearly one million Americans and is characterized by the progressive loss of dopamine-producing neurons, causing tremors, muscle stiffness, and movement difficulties.

The study published in Molecular Neurodegeneration goes beyond linking pesticide exposure to Parkinson’s by uncovering a biological mechanism that could lead to new ways to protect brain cells from damage.

Although genetic factors influence Parkinson’s development, environmental exposures like pesticides have gained attention for their role in the disease, with chlorpyrifos having been used extensively in agriculture before residential use was banned in the U.S. in 2001.

Sources
  1. ScienceDaily Health: Common pesticide linked to 2.5 times the risk of Parkinson’s disease
We read public reporting and official data, confirm what we can, and write our own story. See something wrong? Request a correction.

Comments

No comments yet.

Sign in to comment